This Week $5.74B in Deals and 91 New Life Science Companies

CipherBio Weekly Digest: Week of Jan 13 – 19 2022 This week…

$11.4B for Cardiovascular Disease in Medical Devices

CipherBio PRO Cardiovascular Disease Insight explores the most targeted condition area for…

81 Digital Therapeutics Companies Received $3.1 Billion From 302 Investors

Digital therapeutics are quickly rising in popularity, with the advancement of technology…
Immuno-Oncology Insights

183 Immuno-Oncology Companies Raised $46 Billion

Attempts to harness the immune system to fight cancer date back to the late 1800s. It has been less than 40 years since the first of these immuno-oncology therapies demonstrated success and obtained approval. Since then, nearly 40 cancer immunotherapies have received FDA approval.
Cell Therapy Insights

$18 Billion Invested in 135 Cell Therapy Companies

Cell therapy was born in the 1930s when Paul Niehans earned the…
MicroBiome Insights

64 Microbiome Biotechs Raise $1.6 Billion in Investments

In the last decade, a relatively uncharted field exploded in the life…
CipherBio PRO Eye Disease Insights

Life Science Companies Step Up the Fight Against Vision Loss by raising $13B+ from over 300 investors

The number of adults at risk for vision loss grew substantially from…
Export Investors and Companies by Location

CipherBio PRO Users Explore Hot Markets and Deal Activity by City, State and Country

You dove into the CipherBio ecosystem, discovering companies and investors rooted in…
IPO Insights 2021

Record Breaking Numbers in Life Science IPOs

The number of biotechs entering the public markets is at an all-time…
CipherBio PRO SVB Clients Discounts

SVB Clients Receive Preferred Discounts on CipherBio PRO With Access to $580B+ in Global Life Science VC Funding

SVB Financial Group built and funded CipherBio to help Founders and CEOs…